Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Haemonetics (HAE) Other Working Capital Changes (2016 - 2025)

Haemonetics (HAE) has 17 years of Other Working Capital Changes data on record, last reported at -$18.9 million in Q4 2025.

  • For Q4 2025, Other Working Capital Changes fell 163.19% year-over-year to -$18.9 million; the TTM value through Dec 2025 reached -$19.8 million, down 131.48%, while the annual FY2025 figure was $10.0 million, 70.69% down from the prior year.
  • Other Working Capital Changes reached -$18.9 million in Q4 2025 per HAE's latest filing, down from $21.9 million in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $30.0 million in Q4 2024 and bottomed at -$24.5 million in Q1 2025.
  • Average Other Working Capital Changes over 5 years is $3.4 million, with a median of $2.0 million recorded in 2021.
  • Peak YoY movement for Other Working Capital Changes: surged 1347.94% in 2021, then crashed 303.54% in 2023.
  • A 5-year view of Other Working Capital Changes shows it stood at $2.1 million in 2021, then increased by 6.39% to $2.2 million in 2022, then plummeted by 303.54% to -$4.5 million in 2023, then surged by 759.7% to $30.0 million in 2024, then plummeted by 163.19% to -$18.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Other Working Capital Changes were -$18.9 million in Q4 2025, $21.9 million in Q3 2025, and $1.8 million in Q2 2025.